InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Lee v Tam: The amicus briefs, in brief

Natalie Rahhal, New York


Natalie Rahhal analyses the arguments of the amicus briefs filed in Lee v Tam, ahead of oral arguments in the case involving disparaging trade marks at the US Supreme Court on January 18

The Supreme Court will hear oral arguments in Lee v Tam on Wednesday January 18. The controversial case over the respondent Simon Tam’s attempt to register a trade mark for his band, The Slants, has drawn much media buzz and...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

RT @mdloney: SCOTUS TC Heartland v Kraft Foods Group Brands oral argument transcript is up! https://t.co/v29vEKCILp

Mar 27 2017 07:50 ·  reply ·  retweet ·  favourite
ManagingIP profile

Likely to be an important question for some applicants, with UPC due to come into force in December this year https://t.co/ASuSYUpRqd

Mar 27 2017 04:40 ·  reply ·  retweet ·  favourite
ManagingIP profile

Don't forget to sign up for our next webinar, on IP in Asia, this Thursday at 3pm (London) https://t.co/gh3Ka8t9q1 @inoviaIP @Minesoftnews

Mar 27 2017 04:38 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


March 2017

Roundtable: The second medical use challenge – full transcript

Three leading patent specialists discussed one of the most challenging issues in IP at the moment – incentivising new uses for known drugs – at a recent roundtable discussion. The participants were: Jurgen Dressel, head of global patent litigation strategy, Novartis Pharma; Galit Gonen, VP and general counsel for Europe at Teva; and Professor Sir Robin Jacob, former Court of Appeal judge and professor at the Institute of Brand and Innovation Law, University College London



Most read articles

Supplements